SCHEMBL7769241

SCHEMBL7769241

CCCC(Cl)Oc1ccccc1C=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
LMNA P02545 4/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SRC P12931 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28935895 0.82 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL23209724 0.81 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL28061827 0.78 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL897268 0.77 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL2557672 0.77 PPARG (0.54) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL26090923 0.76 ADRA2A (0.44) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL10588375 0.76 PTGDR2 (0.44) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL11673199 0.75 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL11267013 0.74 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HPGDHTTLMNA
SCHEMBL7879918 0.74 ADRA2A (0.45) ALDH1A1SMN1; SMN2HPGDHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001074810-A2 METHOD FOR USING 2-ARYLOXYALKYLAMINOBENZOXAZOLES AND 2-ARYLOXYALKYLAMINOBENZOTHIAZOLES AS H3 ANTAGONISTS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2001-10-11 WO disclosed